Literature DB >> 8563234

Inhaled nitric oxide in infants with developing or established chronic lung disease.

P A Lönnqvist1, B Jonsson, P Winberg, C G Frostell.   

Abstract

The effect on gas exchange of increasing concentrations of nitric oxide (0-60 parts per million) added to the inspired gases of nine ventilator-dependent infants (median postnatal age = 4 weeks; range 2-16 weeks) with chronic lung disease and pathological oxygenation index values was studied by means of arterial or transcutaneous PO2/PCO2. A significant improvement of oxygenation, indicated by a reduction of oxygenation index, was found (p < 0.014). The optimal nitric oxide concentration and the individual response varied between patients. PO2 returned to baseline values after the discontinuation of nitric oxide in all patients except one. No effect on PCO2 could be identified. Methaemoglobin values only increased marginally during the nitrous oxide exposition (pre-nitric oxide: 0.56% +/- 0.27; post-nitric oxide: 0.78 +/- 0.08; p = ns). Systemic blood pressure and heart rate were unaffected in all patients. Before inhaled nitric oxide can be considered for prolonged use in this patient category further studies regarding long-term efficacy and safety are needed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8563234     DOI: 10.1111/j.1651-2227.1995.tb13522.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

1.  Safety and efficacy of nitric oxide in chronic lung disease.

Authors:  P L Clark; I I Ekekezie; H A Kaftan; C A Castor; W E Truog
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-01       Impact factor: 5.747

2.  Looking beyond PPHN: the unmet challenge of chronic progressive pulmonary hypertension in the newborn.

Authors:  Candice D Fike; Judy L Aschner
Journal:  Pulm Circ       Date:  2013-11-19       Impact factor: 3.017

3.  A pilot study of inhaled nitric oxide in preterm infants treated with nasal continuous positive airway pressure for respiratory distress syndrome.

Authors:  Robert Lindwall; Mats Blennow; Mats Svensson; Baldvin Jonsson; Eva Berggren-Boström; Martino Flanby; Per-Arne Lönnqvist; Claes Frostell; Mikael Norman
Journal:  Intensive Care Med       Date:  2005-03-22       Impact factor: 17.440

4.  Rescue Treatment with L-Citrulline Inhibits Hypoxia-Induced Pulmonary Hypertension in Newborn Pigs.

Authors:  Candice D Fike; Anna Dikalova; Mark R Kaplowitz; Gary Cunningham; Marshall Summar; Judy L Aschner
Journal:  Am J Respir Cell Mol Biol       Date:  2015-08       Impact factor: 6.914

5.  Reactive oxygen species-reducing strategies improve pulmonary arterial responses to nitric oxide in piglets with chronic hypoxia-induced pulmonary hypertension.

Authors:  Candice D Fike; Anna Dikalova; James C Slaughter; M R Kaplowitz; Y Zhang; Judy L Aschner
Journal:  Antioxid Redox Signal       Date:  2013-01-29       Impact factor: 8.401

6.  Tetrahydrobiopterin oral therapy recouples eNOS and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs.

Authors:  Anna Dikalova; Judy L Aschner; Mark R Kaplowitz; Marshall Summar; Candice D Fike
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-08-19       Impact factor: 5.464

Review 7.  Inhaled nitric oxide use in neonates: Balancing what is evidence-based and what is physiologically sound.

Authors:  Laurie G Sherlock; Clyde J Wright; John P Kinsella; Cassidy Delaney
Journal:  Nitric Oxide       Date:  2019-12-19       Impact factor: 4.427

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.